Literature DB >> 11023277

No heritability of temporomandibular joint signs and symptoms.

B S Michalowicz1, B L Pihlstrom, J S Hodges, T J Bouchard.   

Abstract

The causes of temporomandibular joint (TMJ)-related signs and symptoms are largely unknown. We tested the hypotheses that these signs and symptoms, as well as oral parafunctional habits, are substantially heritable. Questionnaire and clinical data were collected from 494 twins, including pairs of reared-apart and reared-together monozygotic (MZ) and dizygotic (DZ) twins. A history of joint-area pain, joint noises, and clenching and grinding habits was scored as present or absent. Twenty-nine percent of the population experienced at least one sign or symptom. Nearly one-quarter of subjects clenched or ground their teeth, and 8.7% reported a history of joint-area pain. Pain was associated with clenching, grinding, and joint noises. MZ twins were no more similar than DZ twins for any outcome, suggesting that genetic factors do not influence these traits in the population. Reared-together MZ twins were no more similar than reared-apart MZ twins, suggesting a negligible effect of the family environment on these outcomes. Environmental factors unique to each twin appeared to be the major determinants of variation in this population.

Entities:  

Mesh:

Year:  2000        PMID: 11023277     DOI: 10.1177/00220345000790080801

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  12 in total

1.  Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.

Authors:  Shad B Smith; Dylan W Maixner; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Richard Ohrbach; Charles Knott; Gary D Slade; Eric Bair; Dustin G Gibson; Dmitri V Zaykin; Bruce S Weir; William Maixner; Luda Diatchenko
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Orofacial pain prospective evaluation and risk assessment study--the OPPERA study.

Authors:  William Maixner; Luda Diatchenko; Ronald Dubner; Roger B Fillingim; Joel D Greenspan; Charles Knott; Richard Ohrbach; Bruce Weir; Gary D Slade
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 3.  Epigenetics and the transition from acute to chronic pain.

Authors:  Thomas Buchheit; Thomas Van de Ven; Andrew Shaw
Journal:  Pain Med       Date:  2012-09-14       Impact factor: 3.750

4.  The phenotype, psychotype and genotype of bruxism.

Authors:  Norma Cruz-Fierro; Margarita Martínez-Fierro; Ricardo M Cerda-Flores; Mayra A Gómez-Govea; Iván Delgado-Enciso; Laura E Martínez-De-Villarreal; Mónica T González-Ramírez; Irám Pablo Rodríguez-Sánchez
Journal:  Biomed Rep       Date:  2018-01-15

5.  A twin study of posttraumatic stress disorder symptoms and chronic widespread pain.

Authors:  Lester M Arguelles; Niloofar Afari; Dedra S Buchwald; Daniel J Clauw; Sylvia Furner; Jack Goldberg
Journal:  Pain       Date:  2006-05-15       Impact factor: 6.961

6.  Orthodontic Treatment, Genetic Factors and Risk of Temporomandibular Disorder.

Authors:  Gary D Slade; Luda Diatchenko; Richard Ohrbach; William Maixner
Journal:  Semin Orthod       Date:  2008-06       Impact factor: 0.970

Review 7.  TMJ disorders: future innovations in diagnostics and therapeutics.

Authors:  Sunil Wadhwa; Sunil Kapila
Journal:  J Dent Educ       Date:  2008-08       Impact factor: 2.264

8.  Are post-traumatic stress disorder symptoms and temporomandibular pain associated? Findings from a community-based twin registry.

Authors:  Niloofar Afari; Yang Wen; Dedra Buchwald; Jack Goldberg; Octavia Plesh
Journal:  J Orofac Pain       Date:  2008

Review 9.  Progress in genetic studies of pain and analgesia.

Authors:  Michael L Lacroix-Fralish; Jeffrey S Mogil
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

Review 10.  Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research.

Authors:  Hyungsuk Kim; David Clark; Raymond A Dionne
Journal:  J Pain       Date:  2009-07       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.